LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Robotic Use Increases to Speed Lab Workflow

By LabMedica International staff writers
Posted on 28 Jun 2017
Image: Without robotics and automation, some labs may be unable to keep pace with testing, and the loss of experienced technicians (Photo courtesy of Lab Automation).
Image: Without robotics and automation, some labs may be unable to keep pace with testing, and the loss of experienced technicians (Photo courtesy of Lab Automation).
Robotic lab automation is making progress and removing some of the labor in laboratories, but rarely is it replacing all functions. Although the most common use of robots is partial, the number of laboratories using them is on the rise. Without robotics and other types of automation, laboratories may be unable to keep pace with testing, the complexities of new tests, such as those involving molecular diagnostics, and the loss of experienced technicians and technologists. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Currently, robotics are finding use in several laboratory processes, ranging from the capping and decapping of sample bottles to high throughput screening. However, one of the major constraints to market growth is the limited adoption of automation and robotics – 10% or less of automation – by small and medium-sized laboratories – those laboratories that process fewer than 100 tubes on a daily basis.

Going forward, much emphasis will be placed on modular robotic automation, which is extremely important for laboratories looking to speed their workflow to keep up with the increasing number of tests, including molecular tests. In order to establish themselves in the market place, robotic systems vendors need to increase productivity and efficiency at laboratories while also helping them to cut costs and errors, and improve productivity. To achieve this, robotics must prove itself as a solution that can address and optimize workflow and many of the phases involved in clinical diagnostics, such as sample collection and sample processing.

“Total lab automation may be appropriate for large-size laboratories, it is not suited for smaller laboratories. It can lead to an increase in the total cost of automation. Moreover, it gives many laboratories little option for future planning, especially if it turns out they do not need to have extensively automated,” said Joe Constance, the author of the study. “Investing in laboratory automation systems is an expensive proposition, and may not be affordable to small and medium-sized laboratories, even if it is a one-time investment.”

Related Links:
Kalorama Information

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hybrid Pipette
SWITCH

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more